In a statement this week, the vaccination developers said that an analysis of 3.8 million Russians who received two doses of Sputnik V between December 5 and March 31 of this year showed that the vaccine was 97.6 percent effective.
“The actual effectiveness of the Sputnik V vaccine may be greater than what our analysis results show, as the data from the case-registration system allow a time lag between sample collection (the actual history of the disease) and the diagnosis.” He said that Sputnik once again confirmed its high effectiveness in preventing infection with the Coronavirus. Alexander Ginsburg, Director of the Aesthetic Institute for Epidemiological and Microbiology Research, It is a statement.
The data, which compares the rate of infection of vaccinated people in an unvaccinated population, will be published in a revised journal next May, according to the Russian Direct Investment Fund and the National Aesthetic Center for Research.
The Russian Ministry of Health keeps a register of people who have been vaccinated, as well as citizens who have contracted the COVID-109 virus as part of the state’s unified health information system.
Whereas, from the date of the first injection to 35 days after that, the incidence was only 0.027%.
Last February, Sputnik V showed 91.6% efficacy in a preliminary analysis of the Phase 3 study.
Data published in the leading medical journal The Lancet showed Sputnik V’s effectiveness at 91.6%. An analysis of data on the infection rate of nearly 4 million vaccinated people in Russia shows that the effectiveness of the vaccine is even higher, reaching 97.6 percent. This data confirms that Sputnik V shows one of the best rates of protection against Coronavirus among all vaccines. The 60 countries that have agreed to use Sputnik V have made the right decision by choosing one of the most effective tools to prevent Coronavirus. ” Kirill Dmitriev, Executive Director of the Russian Direct Investment Fund.
The vaccine has been approved for use in 60 countries with a total population of 3 billion people. Sputnik V ranks second among coronavirus vaccines globally for the number of approvals issued by government regulators.